Serological Evidence of Japanese Encephalitis Virus Circulation in Asian Children From Dengue-Endemic Countries

• Published in: The Journal of infectious diseases Vol. 219; no. 3; pp. 375 - 381
• Main Authors: Nealon, Joshua, Taurel, Anne-Frieda, Yoksan, Sutee, Moureau, Annick, Bonaparte, Matt, Quang, Luong Chan, Capeding, Maria R., Prayitno, Ari, Hadinegoro, Sri Rezeki, Chansinghakul, Danaya, Bouckenooghe, Alain
• Format: Journal Article
• Language: English
• Published: US Oxford University Press 09.01.2019
• Subjects: Adolescent; Asia - epidemiology; Child; Child, Preschool; Children; Dengue - epidemiology; Dengue - immunology; Dengue fever; Dengue Vaccines; Dengue Virus - immunology; Encephalitis; Encephalitis Virus, Japanese - immunology; Encephalitis, Japanese - epidemiology; Encephalitis, Japanese - immunology; Epidemiology; Humans; Indonesia - epidemiology; Infections; Major and Brief Reports; Malaysia - epidemiology; Neurological complications; Neurological diseases; Neutralization Tests; Pediatrics; Philippines - epidemiology; Prevalence; Seroepidemiologic Studies; Serology; Vietnam - epidemiology; VIRUSES; Vietnam; Malaysia; Asia; Philippines; Indonesia; epidemiology; encephalitis; Japanese; seroepidemiologic studies; flavivirus
• ISSN: 0022-1899; 1537-6613; 1537-6613
• DOI: 10.1093/infdis/jiy513

Abstract Background Japanese encephalitis virus (JEV) is a zoonotic, mosquito-borne flavivirus, distributed across Asia. Infections are mostly mild or asymptomatic, but symptoms include neurological disorders, sequelae, and fatalities. Data to inform control strategies are limited due to incomplete case reporting. Methods We used JEV serological data from a multicountry Asian dengue vaccine study in children aged 2–14 years to describe JEV endemicity, measuring antibodies by plaque reduction neutralization test (PRNT50). Results A total 1479 unvaccinated subjects were included. A minimal estimate of pediatric JEV seroprevalence in dengue-naive individuals was 8.1% in Indonesia, 5.8% in Malaysia, 10.8% in the Philippines, and 30.7% in Vietnam, translating to annual infection risks varying from 0.8% (in Malaysia) to 5.2% (in Vietnam). JEV seroprevalence and annual infection estimates were much higher in children with history of dengue infection, indicating cross-neutralization within the JEV PRNT50 assay. Conclusions These data confirm JEV transmission across predominantly urban areas and support a greater emphasis on JEV case finding, diagnosis, and prevention. Japanese encephalitis virus circulation has been demonstrated in urban areas of Indonesia, Malaysia, the Philippines, and Vietnam. Serological data indicate that up to 5% of children are infected annually.